Cargando…

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma

Background: The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for some tumors, few of them significantly prolong the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Rong, Liu, Xiaomeng, Liang, Chen, Hua, Jie, Xu, Jin, Wang, Wei, Meng, Qingcai, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987951/
https://www.ncbi.nlm.nih.gov/pubmed/33777046
http://dx.doi.org/10.3389/fimmu.2021.648917
_version_ 1783668692336246784
author Tang, Rong
Liu, Xiaomeng
Liang, Chen
Hua, Jie
Xu, Jin
Wang, Wei
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
author_facet Tang, Rong
Liu, Xiaomeng
Liang, Chen
Hua, Jie
Xu, Jin
Wang, Wei
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
author_sort Tang, Rong
collection PubMed
description Background: The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for some tumors, few of them significantly prolong the survival of patients with PDAC due to insufficient knowledge on the tumor microenvironment. Methods: A single-cell RNA sequencing (scRNA-seq) dataset and seven PDAC cohorts with complete clinical and bulk sequencing data were collected for bioinformatics analysis. The relative proportions of each cell type were estimated using the gene set variation analysis (GSVA) algorithm based on the signatures identified by scRNA-seq or previous literature. Results: A meta-analysis of 883 PDAC patients showed that neutrophils are associated with worse overall survival (OS) for PDAC, while CD8+ T cells, CD4+ T cells, and B cells are related to prolonged OS for PDAC, with marginal statistical significance. Seventeen cell categories were identified by clustering analysis based on single-cell sequencing. Among them, CD8+ T cells and NKT cells were universally exhausted by expressing exhaustion-associated molecular markers. Interestingly, signatures of CD8+ T cells and NKT cells predicted prolonged OS for PDAC only in the presence of “targets” for pyroptosis and ferroptosis induction. Moreover, a specific state of T cells with overexpression of ribosome-related proteins was associated with a good prognosis. In addition, the hematopoietic stem cell (HSC)-like signature predicted prolonged OS in PDAC. Weighted gene co-expression network analysis identified 5 hub genes whose downregulation may mediate the observed survival benefits of the HSC-like signature. Moreover, trajectory analysis revealed that myeloid cells evolutionarily consisted of 7 states, and antigen-presenting molecules and complement-associated genes were lost along the pseudotime flow. Consensus clustering based on the differentially expressed genes between two states harboring the longest pseudotime span identified two PDAC groups with prognostic differences, and more infiltrated immune cells and activated immune signatures may account for the survival benefits. Conclusion: This study systematically investigated the prognostic implications of the components of the PDAC tumor microenvironment by integrating single-cell sequencing and bulk sequencing, and future studies are expected to develop novel targeted agents for PDAC treatment.
format Online
Article
Text
id pubmed-7987951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79879512021-03-25 Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma Tang, Rong Liu, Xiaomeng Liang, Chen Hua, Jie Xu, Jin Wang, Wei Meng, Qingcai Liu, Jiang Zhang, Bo Yu, Xianjun Shi, Si Front Immunol Immunology Background: The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for some tumors, few of them significantly prolong the survival of patients with PDAC due to insufficient knowledge on the tumor microenvironment. Methods: A single-cell RNA sequencing (scRNA-seq) dataset and seven PDAC cohorts with complete clinical and bulk sequencing data were collected for bioinformatics analysis. The relative proportions of each cell type were estimated using the gene set variation analysis (GSVA) algorithm based on the signatures identified by scRNA-seq or previous literature. Results: A meta-analysis of 883 PDAC patients showed that neutrophils are associated with worse overall survival (OS) for PDAC, while CD8+ T cells, CD4+ T cells, and B cells are related to prolonged OS for PDAC, with marginal statistical significance. Seventeen cell categories were identified by clustering analysis based on single-cell sequencing. Among them, CD8+ T cells and NKT cells were universally exhausted by expressing exhaustion-associated molecular markers. Interestingly, signatures of CD8+ T cells and NKT cells predicted prolonged OS for PDAC only in the presence of “targets” for pyroptosis and ferroptosis induction. Moreover, a specific state of T cells with overexpression of ribosome-related proteins was associated with a good prognosis. In addition, the hematopoietic stem cell (HSC)-like signature predicted prolonged OS in PDAC. Weighted gene co-expression network analysis identified 5 hub genes whose downregulation may mediate the observed survival benefits of the HSC-like signature. Moreover, trajectory analysis revealed that myeloid cells evolutionarily consisted of 7 states, and antigen-presenting molecules and complement-associated genes were lost along the pseudotime flow. Consensus clustering based on the differentially expressed genes between two states harboring the longest pseudotime span identified two PDAC groups with prognostic differences, and more infiltrated immune cells and activated immune signatures may account for the survival benefits. Conclusion: This study systematically investigated the prognostic implications of the components of the PDAC tumor microenvironment by integrating single-cell sequencing and bulk sequencing, and future studies are expected to develop novel targeted agents for PDAC treatment. Frontiers Media S.A. 2021-03-10 /pmc/articles/PMC7987951/ /pubmed/33777046 http://dx.doi.org/10.3389/fimmu.2021.648917 Text en Copyright © 2021 Tang, Liu, Liang, Hua, Xu, Wang, Meng, Liu, Zhang, Yu and Shi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Tang, Rong
Liu, Xiaomeng
Liang, Chen
Hua, Jie
Xu, Jin
Wang, Wei
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title_full Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title_fullStr Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title_short Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
title_sort deciphering the prognostic implications of the components and signatures in the immune microenvironment of pancreatic ductal adenocarcinoma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987951/
https://www.ncbi.nlm.nih.gov/pubmed/33777046
http://dx.doi.org/10.3389/fimmu.2021.648917
work_keys_str_mv AT tangrong decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT liuxiaomeng decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT liangchen decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT huajie decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT xujin decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT wangwei decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT mengqingcai decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT liujiang decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT zhangbo decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT yuxianjun decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma
AT shisi decipheringtheprognosticimplicationsofthecomponentsandsignaturesintheimmunemicroenvironmentofpancreaticductaladenocarcinoma